DUBLIN--(BUSINESS WIRE)--The "Sustained Release Excipients Market Size, Share & Trends Analysis Report By Product (Polymers, Gelatin), By Route of Administration (Oral, Transdermal), By Technology (Targeted Delivery), And Segment Forecasts, 2018 - 2026" report has been added to ResearchAndMarkets.com's offering.
The global sustained release excipients market size is expected to reach USD 1.6 billion by 2026 at a 7.1% CAGR during the forecast period
Increasing focus on novel drug delivery R&D and rising adoption of extended release formulations for treatment of chronic diseases are major factors driving the market.
Use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits. Reduced dosage frequency, improved patient compliance, maintenance of constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness in the long run are some of the major advantages of using this technology.
Global rise in incidence of chronic and infectious diseases has also resulted in antibiotic resistance, which negatively affects the market for conventional dosage forms. Thus, alternative methods to manage and treat these diseases are being implemented. Use of sustained release formulations has been widely accepted among physicians in order to combat antibiotic resistance.
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Sustained Release Excipients Market Variables, Trends & Scope
Chapter 4 Sustained Release Excipients Market: Product Estimates & Trend Analysis
Chapter 5 Sustained Release Excipients Market: Route of Administration Estimates & Trend Analysis
Chapter 6 Sustained Release Excipients Market: Technology Estimates & Trend Analysis
Chapter 7 Sustained Release Excipients Market: Regional Estimates & Trend Analysis, by Product, Route of Administration, and Technology
Chapter 8 Competitive Landscape: Sustained Release Drugs
Chapter 9 Competitive Landscape: Sustained Release Technology
Chapter 10 Product Pipeline Analysis
- Depomed, Inc.
- Coating Place, Inc.
- Corium International, Inc.
- Orbis Biosciences, Inc.
- Aradigm Corporation
- Alkermes plc
For more information about this report visit https://www.researchandmarkets.com/research/kr2r9d/global_sustained?w=4